The World Health Organization (WHO) and its partners have agreed to launch a programme for claims of serious side effects among people in 92 poorer countries due to Covid-19 vaccination, the WHO said Monday in a statement.
"This is the first and only global vaccine injury compensation mechanism" operating on an international scale, the WHO statement said.
According to WHO, the programme, No-Fault Compensation, will offer eligible individuals "a fast, fair, robust and transparent process to receive compensation for rare but serious adverse events associated with COVAX-distributed vaccines until June 30 2022."
COVAX is a facility led by WHO for better Covid-19 vaccine distribution. The statement said all vaccines procured or distributed through COVAX receive regulatory approval or an emergency use authorization to confirm their safety and efficacy.
"But, as with all medicines, even vaccines that are approved for general use may, in rare cases, cause serious adverse reactions," WHO said.
"By providing a no-fault lump-sum compensation in full and final settlement of any claims, the COVAX programme aims to significantly reduce the need for recourse to the law courts, a potentially lengthy and costly process," said the statement.
By providing a mechanism to settle serious adverse events, the compensation program could help those who might have such effects, and help manufacturers to roll out vaccines to countries faster, said Seth Berkley, CEO of the Vaccine Alliance Gavi, in the statement.
The programme will be operated by ESIS, a subsidiary of the Zurich-based multinational insurance company Chubb Limited, the WHO said, adding that the compensation mechanism is to be funded by Gavi through a "levy charged on all doses of Covid-19 vaccines distributed through the COVAX Facility".
WHO Director-General Tedros Adhanom Ghebreyesus praised the agreement, saying that this agreement offers further protection and confidence in the life-saving power of vaccines.
As the world is struggling to contain the pandemic, vaccination is underway in some countries with the already-authorized coronavirus vaccines.
Meanwhile, 251 candidate vaccines are still being developed worldwide -- 70 of them in clinical trials - in countries including Germany, China, Russia, Britain and the United States, according to information released by WHO on February 19.
Latest Stories
-
Burnley score late to draw with Manchester United at Old Trafford
2 hours -
Bayer Leverkusen extend unbeaten run to 46 games after draw with Stuttgart
2 hours -
Chelsea come from two goals down to draw against Aston Villa
2 hours -
Andre Ayew scores in Le Havre’s 3-3 draw with PSG
2 hours -
GPL 2023/24: Kotoko draw with Medeama; Samartex go 7 points clear of Nations FC
3 hours -
Mahama cuts sod for construction of new multipurpose Jakpa palace in Damongo
3 hours -
NSS management assists Papao fire victims
3 hours -
EXPLAINER: Will dumsor end soon?
4 hours -
IMANI Africa takes on EC, accuses it of lying and publishing half truths
5 hours -
Manasseh Azure calls for investigation and prosecution of those responsible for GRA/SML contract
5 hours -
Kwesi Atuahene: Ghana’s health capital depends on HealthTech – Africa Center for Digital Transformation
5 hours -
13 signs your wife is planning on leaving you and you have no idea
5 hours -
IMANI Africa: Ghana’s EC’s dangerous and pathological conduct
6 hours -
If I speak there will be fire – Salah on Klopp row
7 hours -
Grieving after divorce is normal, but this particular kind of grief isn’t
7 hours